Recently stock market analysts have updated their consensus ratings on shares of Alimera Sciences, Inc. (ALIM). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

05/06/2016 – Alimera Sciences, Inc. was downgraded to “market perform” by analysts at Cowen.

03/04/2016 – Alimera Sciences, Inc. had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 5 price target on the stock.

05/01/2015 – Alimera Sciences, Inc. was downgraded to “hold” by analysts at Zacks.

11/17/2014 – Summer Street began new coverage on Alimera Sciences, Inc. giving the company a “buy” rating. They now have a USD 12 price target on the stock.

09/29/2014 – Alimera Sciences, Inc. had its “outperform” rating reiterated by analysts at Northland Securities. They now have a USD 10 price target on the stock.

Alimera Sciences, Inc. has a 50 day moving average of 1.98 and a 200 day moving average of 2.41. The stock’s market capitalization is 82.85M, it has a 52-week low of 1.49 and a 52-week high of 5.15.

The share price of the company (ALIM) was down -3.12%, with a high of 1.92during the day and the volume of Alimera Sciences, Inc. shares traded was 207265.

View other investors thoughts on Alimera Sciences, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.